GSA CAPITAL PARTNERS LLP - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 52 filers reported holding ETON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$107,000
-37.4%
24,475
-38.5%
0.01%
-33.3%
Q4 2021$171,000
-58.8%
39,817
-51.6%
0.02%
-50.0%
Q3 2021$415,000
+17.2%
82,314
+43.4%
0.04%
+5.0%
Q2 2021$354,000
+20.8%
57,397
+43.3%
0.04%
-18.4%
Q1 2021$293,00040,0640.05%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,430,270$10,134,2263.30%
Westside Investment Management, Inc. 528,310$2,203,0600.63%
Acuitas Investments, LLC 219,000$913,2300.54%
EAM Investors, LLC 256,623$1,070,1180.21%
Parkman Healthcare Partners LLC 165,000$688,0500.13%
ESSEX INVESTMENT MANAGEMENT CO LLC 110,016$458,7670.08%
PARADIGM CAPITAL MANAGEMENT INC/NY 300,000$1,251,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 271,462$1,131,9970.03%
Quantum Private Wealth, LLC 11,500$47,9550.02%
CHICAGO TRUST Co NA 16,700$69,6390.02%
View complete list of ETON PHARMACEUTICALS INC shareholders